Search - tctmd.com

Displaying 1 - 20 of 115

Sort: Relevancy | Date

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Conference News ESC 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

Caitlin E. Cox

August 31, 2025

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

More Data Show Redlining’s Lasting Impact on CVD Risk

L.A. McKeown

July 14, 2023

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

SCAI Updates Position on Doing PCI Without Surgical Backup

Michael O'Riordan

February 20, 2023

NY State to Exclude Emergency PCI Cases From Public Outcomes Reports

News Daily News

NY State to Exclude Emergency PCI Deaths From Physician-Level Public Reports

Todd Neale

January 04, 2023

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Todd Neale

December 16, 2022

News Daily News

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Michael O'Riordan

November 22, 2022

News Conference News EACTS 2022

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Michael O'Riordan

October 07, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Daily News

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

Michael O'Riordan

May 04, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Advertisement

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

More Data Show Redlining’s Lasting Impact on CVD Risk

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

SCAI Updates Position on Doing PCI Without Surgical Backup

NY State to Exclude Emergency PCI Deaths From Physician-Level Public Reports

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content